![Eyal Attar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Eyal C.
Attar formerly worked at Agios Pharmaceuticals, Inc., as Senior Medical Director from 2016 to 2019, Harvard Medical School, as Member-Leukemia Center, Aprea Therapeutics, Inc., as Chief Medical Officer & Senior Vice President, and Vor Biopharma, Inc., as Chief Medical Officer from 2022 to 2025.
Dr. Attar received his doctorate degree from UNC School of Medicine.
Tidigare kända positioner av Eyal Attar
| Företag | Position | Slut |
|---|---|---|
| VOR BIOPHARMA INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-04-18 |
| AGIOS PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2019-01-01 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
| APREA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Eyal Attars utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
45
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UNC School of Medicine
 UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
